RI
AVDL

RTW Investments’s Avadel Pharmaceuticals AVDL Stock Holding History

RTW Investments’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,798,558
Closed -$149M – 69
2024
Q1 		$149M Buy
8,798,558
+1,850,640
+27% +$27.6M 2.19% 18
2023
Q4 		$98.1M Sell
6,947,918
-188,497
-3% -$2.21M 1.53% 23
2023
Q3 		$73.5M Buy
7,136,415
+325,774
+5% +$4.36M 1.55% 21
2023
Q2 		$112M Buy
6,810,641
+1,068,702
+19% +$13.9M 2.14% 19
2023
Q1 		$52.6M Hold
5,741,939
– – 1.1% 24
2022
Q4 		$41.1M Hold
5,741,939
– – 0.84% 26
2022
Q3 		$28.8M Hold
5,741,939
– – 0.66% 38
2022
Q2 		$14M Hold
5,741,939
– – 0.36% 48
2022
Q1 		$39.2M Hold
5,741,939
– – 0.81% 38
2021
Q4 		$46.4M Hold
5,741,939
– – 0.68% 47
2021
Q3 		$56.3M Hold
5,741,939
– – 0.85% 34
2021
Q2 		$38.6M Hold
5,741,939
– – 0.58% 44
2021
Q1 		$51.9M Buy
5,741,939
+354,426
+7% +$2.87M 0.81% 37
2020
Q4 		$36M Buy
5,387,513
+20,808
+0.4% +$130K 0.6% 41
2020
Q3 		$27M Buy
5,366,705
+60,135
+1% +$438K 0.65% 40
2020
Q2 		$42.9M Buy
5,306,570
+690,000
+15% +$6.08M 1.21% 29
2020
Q1 		$36.3M Buy
4,616,570
+1,215,136
+36% +$9.33M 1.56% 23
2019
Q4 		$25.7M Buy
+3,401,434
New +$18M 0.97% 29

Other funds holding AVDL

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RTW Investments's AVDL Position: Q2 2024 in Review

RTW Investments sold out of Avadel Pharmaceuticals (AVDL) in Q2 2024, closing a stake of 8,798,558 shares — an estimated $149M sold.

RTW Investments first reported a position in AVDL in Q4 2019 and held it in 18 quarters. The position peaked at $149M in Q1 2024. 155 funds tracked by Wall St. Rank hold AVDL as of Q2 2024.

  • RTW Investments reported no remaining Avadel Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • RTW Investments sold 8,798,558 Avadel Pharmaceuticals shares in Q2 2024, an estimated $149M.
  • RTW Investments first reported a position in Avadel Pharmaceuticals in Q4 2019 and held it in 18 quarters.
  • RTW Investments's Avadel Pharmaceuticals position peaked at $149M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2024.

Based on RTW Investments's 13F filing for Q2 2024, filed 14 Aug 2024.